Ioversol Market - Forecast(2024 - 2030)

Report Code: CMR 81466 Report Format: PDF + Excel

Ioversol Market Overview

Ioversol Market size is expected to be valued at $857 million by the end of the year 2026 and is set to grow at a CAGR of 7.2% during the forecast period from 2021-2026. Ioversol is an organoiodine compound that is found in everyday iodine salt composition and is mandated by the government for health reasons. Ioversol are sterile contrast dye used in diagnostic radiocontrast agent administered for patients during CT scans and X-ray procedures for increasing the image contrast. Therefore, the increase in the incidence of number of patients suffering from heart diseases and respiratory diseases is giving raise to the demand of ioversol market. The growth in the healthcare infrastructure across the globe is further driving the ioversol market.

COVID-19 impact

Amid the Covid-19 pandemic, the ioversol market saw a considerable amount of growth owing to the increase in demand from the hospitals. There was a lot of side effects caused by Covid-19 which created medical complications among patients. There are a lot of CT scans and X-rays done during the time of pandemic, to detect further complications in patients. This has highly increased the demand for Ioversol market. Furthermore, the ioversol market is set to rapidly grow by the year end of 2021.

Report Coverage

The report: “Ioversol Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Ioversol Industry.
By Type: Ioversol 34% Injectable Solution, Ioversol 51% Injectable Solution, Ioversol 64% Injectable Solution, Ioversol 68% Injectable Solution and Ioversol 74% Injectable Solution.
By Packaging: Vials, Bottles, Hand-Held Syringes and Power Injector Syringes.
By Application: X-ray, CT scan, Radiological & Diagnostic Examinations, Angiography, Urography, Computed Tomographic Scans and Others.
By Geography: North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, France, Netherlands, Belgium Spain, Russia and Rest of Europe), APAC (China, Japan India, South Korea, Australia, New Zealand, Indonesia, Taiwan, Malaysia), South America (Brazil, Argentina, Colombia, Chile and Rest of South America) and RoW (Middle East and Africa). 

Key Takeaways

  • North American market held the largest share in the ioversol market owing to the growing healthcare infrastructure and increase in demand from hospitals for image testing on cardiovascular patients.
  • The increase in the incidence of number of accidents across the globe is giving rise to the need for scanning and X-ray procedures which is further driving the Ioversol market.
  • Increasing diseases and health conditions in patients across the globe is driving the ioversol market.
  • Amid the Covid-19 pandemic, the ioversol market witnessed a considerable amount of growth owing to the increase in the diseases and health conditions during the pandemic.

FIGURE: Ioversol Market Revenue, 2020-2026 (US$ Million)

Ioversol Market

For more details on this report - Request for Sample

Ioversol Market Segment Analysis – By Type

Ioversol 64% Injectable Solution segment held the largest share of 30% in the Ioversol market in the year 2020. Ioversol 34% Injectable Solution is widely used in radiographic body imaging owing to the scope of application, ease of use and low cost. Radiographic body imaging is done to take pictures or image parts of human body. Diagnostic radiocontrast agent is administered to patients in the radiographic body imaging to increase the contrast of the image. The increase in the incidents of road mishaps and other accidents is increasing the demand for diagnostic radiocontrast agent, which is further driving the demand for Ioversol 64% injectable solution segment in the ioversol market.

Ioversol Market Segment Analysis – By Packaging

Power Injector Syringes segment held the largest share of 33% in the Ioversol market in the year 2020. Power Injector Syringes is a Food and Drug Administration authorized tubing kits used in CT and MRI processes. Power injector syringes are affordable and easy to use. The increase in the need for administering contrast dye to patients, is increasing the demand for power injector syringes in the ioversol market. The diagnostic radiocontrast agent or contrast dye solution can be easily stored in the power injector systems and can also be used for administering it to the patient. Therefore, it is driving the power injector systems in the ioversol market.

Ioversol Market Segment Analysis – By Application

Radiological & Diagnostic Examinations segment held the largest share of 40% in the ioversol market in the year 2020. There are various methods and processes under radiological and diagnostic examinations that is done in various medical conditions and situations. Diagnostic radiocontrast agents are used in magnetic resonance imaging (MRI) scans, coronary calcium scoring and various other procedures. According to World Health Organization (WHO), almost 1.3 million people die every year across the world due to road accidents. Road traffic crashes cost most countries 3% of their gross domestic product. This is increasing the possibility of traumatic brain injuries, which is further increasing the demand for ioversol market. 

Ioversol Market Segment Analysis – By Geography

North American region held the largest share of 42% in the ioversol market in the year 2020. The increase in the growth of the medical and healthcare system in the North America region is majorly driving the ioversol market. According to National Health Expenditure Accounts (NHEA), the US healthcare spending grew by 4.6% in the year 2019 reaching US11,583 per person in the US. According to Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial and ethnic groups in United States. According to Heart disease and stroke statistics—2020 update: a report from the American Heart Association, about 655,000 Americans die from heart disease every year, that is 1 in every 4 deaths. Furthermore, a mysterious case of brain disease was reported in few people in Canada during the beginning of the year 2021 by the Canadian government. This further increased the demand for diagnostic tests in Canada, which is further driving the ioversol market in the region.

Ioversol Market Drivers

Increasing case of heart diseases

The increased case of heart diseases among various age groups and genders across the globe is one of the important factors driving the demand for ioversol market. According to World Health Organization (WHO), 16% of the total deaths were caused due to ischaemic heart disease across the world. There were reported cases of 8.9 million deaths due to heart related conditions in the year 2020. Heart disease has been the leading cause of death at global level since the last 20 years. The increase in heart conditions is giving rise to the demand for contrast dye in taking coronary calcium scan and angioplasty. This is further driving the ioversol market. 

Increasing brain-related health conditions

There has been an increase in cases of brain related health conditions across various age groups across the globe. The brain disease can be linked to various factors such as change in lifestyles, increase in use of mobile phones that radiates waves and various other reasons. There has also been an increasing cases of dementia among geriatric population, which is causing brain related problems among patients. There have been reported cases of 50 million patients with dementia as of the year 2020 and with 10 million cases every year. Furthermore, during 2019, there were reported cases of around 50 million patients with epilepsy, a central nervous system disorder related to brain. This is further driving the demand for ioversol market. 

Ioversol Market Challenges

Adverse effects of Ioversol

Ioversol has certain adverse effects of humans, that could be dangerous to human. When ioversol is not administered properly, it could lead to further complications. The complications sometimes could even end in fatality. The other adverse effects could include convulsions, cerebral haemorrhage, paralysis, renal failure, cardiac arrest, seizures and various other dangerous complications. Therefore, it needs to be administered only by experienced and trained professionals, and it could still cause complications. Therefore, this is one of the major challenges restricting the growth of the ioversol market.

Ioversol Market Industry Outlook

Investments, acquisitions and mergers, production expansion, collaborations, facility expansion and partnerships are some of the key strategies adopted by players in the Ioversol Market. Major players in the Ioversol Market are Liebel-Flarsheim Company LLC, Jiangsu Hengrui Medicine Co, Ultraject, Stellence Pharmscience Pvt. Ltd, China Resources Pharmaceutical (Shanghai) Co, A.S. Joshi & Company, Mallinckrodt Pharmaceuticals, Novalek Pharmaceuticals Pvt. Ltd, HB Ocean and Guerbet among others.

Acquisitions/Technology Launches

  • In December 2020, Guerbet released Optiray Imaging Bulk Package, commercially in the USA with approval from US Food and Drug Administration. This helped the company in tackling the increased demand from public.  

Relevant Reports

Analgesics Market – Forecast (2021 - 2026)

Report Code: HCR 0116

Methadone Market - Forecast (2021-2026)

Report Code: HCR 71257

 For more Chemicals and Materials related reports, please click here

1. Ioversol Market- Market Overview
    1.1 Definitions and Scope
2. Ioversol Market - Executive Summary
    2.1 Key Trends by Type
    2.2 Key Trends by Packaging
    2.3 Key Trends by Application
    2.4 Key Trends by Geography
3. Ioversol Market – Comparative analysis
    3.1 Market Share Analysis- Major Companies
    3.2 Product Benchmarking- Major Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis- Major Companies
    3.5 Pricing Analysis (ASPs will be provided)
4. Ioversol Market - Startup companies Scenario Premium Premium
    4.1 Major startup company analysis:
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Product portfolio
        4.1.4 Venture Capital and Funding Scenario
5. Ioversol Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Successful Venture Profiles
    5.4 Customer Analysis – Major companies
6. Ioversol Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Buyers
        6.3.3 Threat of New Entrants
        6.3.4 Competitive Rivalry
        6.3.5 Threat of Substitutes
7. Ioversol Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunity Analysis
    7.3 Product/Market Life Cycle
    7.4 Distributor Analysis – Major Companies
8. Ioversol Market – By Type (Market Size -$Million/Billion)
    8.1 Ioversol 34% Injectable Solution
    8.2 Ioversol 51% Injectable Solution
    8.3 Ioversol 64% Injectable Solution
    8.4 Ioversol 68% Injectable Solution
    8.5 Ioversol 74% Injectable Solution
9. Ioversol Market – By Packaging (Market Size -$Million/Billion)
    9.1 Vials
    9.2 Bottles
    9.3 Hand-Held Syringes
    9.4 Power Injector Syringes
10. Ioversol Market – By Application (Market Size -$Million/Billion)
    10.1 X-ray
    10.2 CT Scan
    10.3 Radiological & Diagnostic Examinations
    10.4 Angiography
    10.5 Urography
    10.6 Computed Tomographic Scans
    10.7 Others
11. Ioversol Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 USA
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 UK
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Netherlands
        11.2.6 Spain
        11.2.7 Russia
        11.2.8 Belgium
        11.2.9 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 India
        11.3.4 South Korea
        11.3.5 Australia and New Zealand
        11.3.6 Indonesia
        11.3.7 Taiwan
        11.3.8 Malaysia
        11.3.9 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Colombia
        11.4.4 Chile
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
            11.5.1.1 Saudi Arabia
            11.5.1.2 UAE
            11.5.1.3 Israel
            11.5.1.4 Rest of the Middle East
        11.5.2 Africa
            11.5.2.1 South Africa
            11.5.2.2 Nigeria
            11.5.2.3 Rest of Africa
12. Ioversol Market – Entropy
    12.1 New Product Launches
    12.2 M&As, Collaborations, JVs and Partnerships
13. Ioversol Market – Industry/Segment Competition Landscape Premium
    13.1 Company Benchmarking Matrix- Major Companies
    13.2 Market Share at Global Level - Major companies
    13.3 Market Share by Key Region - Major companies
    13.4 Market Share by Key Country - Major companies
    13.5 Market Share by Key Application - Major companies
    13.6 Market Share by Key Product Type/Product category - Major companies
14. Ioversol Market – Key Company List by Country Premium Premium
15. Ioversol Market Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"